Kleene S
Pflugers Arch. 2024; 477(3):479-494.
PMID: 39688695
DOI: 10.1007/s00424-024-03050-8.
Wang S, Kang Y, Xie H
Cells. 2024; 13(20.
PMID: 39451240
PMC: 11506562.
DOI: 10.3390/cells13201722.
Van Sciver R, Caspary T
Dis Model Mech. 2024; 17(10).
PMID: 39263856
PMC: 11512102.
DOI: 10.1242/dmm.052000.
Staudner T, Geiges L, Khamseekaew J, Sure F, Korbmacher C, Ilyaskin A
J Biol Chem. 2024; 300(8):107574.
PMID: 39009345
PMC: 11630642.
DOI: 10.1016/j.jbc.2024.107574.
Lapin B, Gropplero G, Vandensteen J, Mazloum M, Bienaime F, Descroix S
bioRxiv. 2024; .
PMID: 38948811
PMC: 11212944.
DOI: 10.1101/2024.06.18.599137.
Oral delivery of nanomedicine for genetic kidney disease.
Huang Y, Wang J, Mancino V, Pham J, OGrady C, Li H
PNAS Nexus. 2024; 3(5):pgae187.
PMID: 38807632
PMC: 11131023.
DOI: 10.1093/pnasnexus/pgae187.
Cilia-deficient renal tubule cells are primed for injury with mitochondrial defects and aberrant tryptophan metabolism.
Zuo X, Winkler B, Lerner K, Ilatovskaya D, Zamaro A, Dang Y
Am J Physiol Renal Physiol. 2024; 327(1):F61-F76.
PMID: 38721661
PMC: 11390130.
DOI: 10.1152/ajprenal.00225.2023.
Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease.
Zhang C, Rehman M, Tian X, Pei S, Gu J, Bell 3rd T
Nat Commun. 2024; 15(1):3698.
PMID: 38693102
PMC: 11063051.
DOI: 10.1038/s41467-024-48025-6.
Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression.
Clerici S, Podrini C, Stefanoni D, Distefano G, Cassina L, Steidl M
EMBO Mol Med. 2024; 16(6):1379-1403.
PMID: 38684863
PMC: 11178866.
DOI: 10.1038/s44321-024-00071-9.
Mechanistic complement of autosomal dominant polycystic kidney disease: the role of aquaporins.
Lan Q, Li J, Zhang H, Zhou Z, Fang Y, Yang B
J Mol Med (Berl). 2024; 102(6):773-785.
PMID: 38668786
DOI: 10.1007/s00109-024-02446-4.
Overexpression of SMYD3 Promotes Autosomal Dominant Polycystic Kidney Disease by Mediating Cell Proliferation and Genome Instability.
Agborbesong E, Zhou J, Zhang H, Li L, Harris P, Calvet J
Biomedicines. 2024; 12(3).
PMID: 38540216
PMC: 10968571.
DOI: 10.3390/biomedicines12030603.
Emerging mechanistic understanding of cilia function in cellular signalling.
Hilgendorf K, Myers B, Reiter J
Nat Rev Mol Cell Biol. 2024; 25(7):555-573.
PMID: 38366037
PMC: 11199107.
DOI: 10.1038/s41580-023-00698-5.
Primary cilia and actin regulatory pathways in renal ciliopathies.
Kalot R, Sentell Z, Kitzler T, Torban E
Front Nephrol. 2024; 3:1331847.
PMID: 38292052
PMC: 10824913.
DOI: 10.3389/fneph.2023.1331847.
A synthetic agent ameliorates polycystic kidney disease by promoting apoptosis of cystic cells through increased oxidative stress.
Fedeles B, Bhardwaj R, Ishikawa Y, Khumsubdee S, Krappitz M, Gubina N
Proc Natl Acad Sci U S A. 2024; 121(4):e2317344121.
PMID: 38241440
PMC: 10823221.
DOI: 10.1073/pnas.2317344121.
Deletion of Aurora kinase A prevents the development of polycystic kidney disease in mice.
Tham M, Cottle D, Zylberberg A, Short K, Jones L, Chan P
Nat Commun. 2024; 15(1):371.
PMID: 38191531
PMC: 10774271.
DOI: 10.1038/s41467-023-44410-9.
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies.
Moran A, Louzao-Martinez L, Norris D, Peters D, Blacque O
Nat Rev Nephrol. 2023; 20(2):83-100.
PMID: 37872350
DOI: 10.1038/s41581-023-00773-2.
Fibrocystin/Polyductin releases a C-terminal fragment that translocates into mitochondria and suppresses cystogenesis.
Walker R, Yao Q, Xu H, Maranto A, Swaney K, Ramachandran S
Nat Commun. 2023; 14(1):6513.
PMID: 37845212
PMC: 10579373.
DOI: 10.1038/s41467-023-42196-4.
Emerging principles of primary cilia dynamics in controlling tissue organization and function.
Gopalakrishnan J, Feistel K, Friedrich B, Grapin-Botton A, Jurisch-Yaksi N, Mass E
EMBO J. 2023; 42(21):e113891.
PMID: 37743763
PMC: 10620770.
DOI: 10.15252/embj.2023113891.
Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.
Jung H, Dixon E, Coleman R, Watnick T, Reiter J, Outeda P
Physiol Genomics. 2023; 55(11):565-577.
PMID: 37720991
PMC: 11178268.
DOI: 10.1152/physiolgenomics.00040.2023.
CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease.
Yanda M, Ciobanu C, Guggino W, Cebotaru L
Am J Physiol Cell Physiol. 2023; 325(3):C682-C693.
PMID: 37519231
PMC: 10635646.
DOI: 10.1152/ajpcell.00197.2023.